Are we really looking the right way at resistant BCR-ABL1 kinase domain mutations in chronic myeloid leukemia?

被引：0
|
作者：
Pricl, S. [1 ]
Laurini, E. [1 ]
Fermeglia, M. [1 ]
Donato, N. J. [2 ]
Cardama, A. Q. [3 ]
机构：
[1] Univ Trieste, MOSE DEA, Trieste, Italy
[2] Univ Michigan, Dept Pharmacol, Ctr Comprehens Canc, Div Hematol Oncol, Ann Arbor, MI 48109 USA
[3] Novartis Pharma AG, Cell & Gene Therapies Unit, Basel, Switzerland
来源：
EUROPEAN JOURNAL OF CANCER | 2016年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P127-H005
引用
收藏
页码：S43 / S43
页数：1
相关论文
共 50 条
  • [1] Mutations in the BCR-ABL1 Kinase Domain and Elsewhere in Chronic Myeloid Leukemia
    Soverini, Simona
    de Benedittis, Caterina
    Mancini, Manuela
    Martinelli, Giovanni
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S120 - S128
  • [2] Reflexive Screening for BCR-ABL1 Kinase Domain Mutations in Chronic Myeloid Leukemia
    Langabeer, Stephen E.
    McCarron, Sarah L.
    Haslam, Karl
    Preston, Lisa
    [J]. CLINICAL LABORATORY, 2016, 62 (05) : 975 - 976
  • [3] STUDY OF MUTATIONS IN THE KINASE DOMAIN OF BCR-ABL1 BY NGS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA
    Stuckey, Ruth
    Florido, Ortega Yanira
    Rodriguez, Lopez Juan Francisco
    Bilbao, Sieyro Cristina
    Gomez, Casares Maria Teresa
    [J]. HAEMATOLOGICA, 2020, 105 : 239 - 239
  • [4] A Novel BCR-ABL1 Degrader, Ubx-362, Can Overcome Resistance By BCR-ABL1 Kinase Domain Mutations in Chronic Myeloid Leukemia
    Lim, Ye Seul
    Jeong, Na-Rae
    Yoo, Sun-Mi
    Kim, Han Wool
    Lee, Song Hee
    Kim, Dong-Wook
    [J]. BLOOD, 2023, 142
  • [5] Deep sequencing of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia patients with resistance to tyrosine kinase inhibitors
    Erbilgin, Yucel
    Eskazan, Ahmet Emre
    Ng, Ozden Hatirnaz
    Salihoglu, Ayse
    Elverdi, Tugrul
    Firtina, Sinem
    Tasar, Orcun
    Mercan, Sevcan
    Sisko, Sinem
    Khodzhaev, Khusan
    Ongoren, Seniz
    Ar, Muhlis Cem
    Baslar, Zafer
    Soysal, Teoman
    Sayitoglu, Muge
    Ozbek, Ugur
    [J]. LEUKEMIA & LYMPHOMA, 2019, 60 (01) : 200 - 207
  • [6] Implications of BCR-ABL1 kinase domain-mediated resistance in chronic myeloid leukemia
    Soverini, Simona
    Branford, Susan
    Nicolini, Franck E.
    Talpaz, Moshe
    Deininger, Michael W. N.
    Martinelli, Giovanni
    Mueller, Martin C.
    Radich, Jerald P.
    Shah, Neil P.
    [J]. LEUKEMIA RESEARCH, 2014, 38 (01) : 10 - 20
  • [7] Chronic Myeloid Leukemia: Beyond BCR-ABL1
    Zhou, Ting
    Medeiros, L. Jeffrey
    Hu, Shimin
    [J]. CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2018, 13 (06) : 435 - 445
  • [8] Chronic Myeloid Leukemia: Beyond BCR-ABL1
    Ting Zhou
    L. Jeffrey Medeiros
    Shimin Hu
    [J]. Current Hematologic Malignancy Reports, 2018, 13 : 435 - 445
  • [9] Mutational analysis of tyrosine kinase domain of BCR-ABL1 gene in chronic myeloid leukemia patients resistant to tyrosine kinase inhibitors
    Kihel, I.
    Nachi, M.
    Cayuela, J.
    Bekadja, M. A.
    Note, A.
    [J]. CLINICA CHIMICA ACTA, 2024, 558
  • [10] Mutations in the BCR-ABL1 kinase domain in patients with chronic myeloid leukaemia treated with TKIs or at diagnosis
    Liu, Jingjing
    Yang, Haiping
    Xu, Xiuwen
    Yi, Shujuan
    Meng, Li
    [J]. ONCOLOGY LETTERS, 2020, 20 (02) : 1071 - 1076
12345